and Human Services (HHS)
EXPIRED
Participating Organization(s) |
National Institutes of Health (NIH) |
Division of Program Coordination, Planning and Strategic
Initiatives, |
|
Funding Opportunity Title |
Administrative Supplements for Research on Sex/Gender Differences (Admin Supp) |
Activity Code |
Administrative Supplement Additional funds may be awarded as supplements to parent awards using the following Activity Code(s): Administrative supplement requests must be submitted on paper for the following activity codes: P01 Research Program Projects Administrative supplement requests may be submitted electronically for the following activity codes: DP1 NIH Director’s Pioneer Award (NDPA) |
Announcement Type |
Reissue of PA-13-018 |
Related Notices |
|
Funding Opportunity Announcement (FOA) Number |
PA-14-027 |
Companion Funding Opportunity |
None |
Only one application per parent award is allowed as defined in Section III. 3. Additional Information on Eligibility. |
|
Catalog of Federal Domestic Assistance (CFDA) Number(s) |
93.839; 93.838; 93.837; 93.233; 93.856; 93.855; 93.879; ; 93.286; 93.867; 93.399; 93.396; 93.395; 93.394; 93.393; 93.273; 93.866; 93.859; 93.242; 93.865; 93.307; 93.989; 93.847; 93.173; 93.113; 93.213; 93.121; 93.279; 93.853; 93.846, 93.313 |
Funding Opportunity Purpose |
The Office of Research on Women's Health (ORWH) announces the availability of administrative supplements to support research highlighting the impact of sex/gender differences (or similarities) and/or sex and gender factors in human health and illness, including preclinical, clinical and behavioral studies. Of special interest are studies relevant to the molecular and cellular and systems biology bases of disease and pathophysiology, clinical presentation, and prevention and treatment of disease. The proposed research should address at least one objective from Goals 1 through 3 of the NIH Strategic Plan for Women's Health Research. |
Posted Date |
December 11, 2013 |
Open Date (Earliest Submission Date) |
January 6, 2014 |
Letter of Intent Due Date(s) |
Not Applicable |
Application Due Date(s) |
February 6, 2014 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
Not Applicable |
Scientific Merit Review |
Not Applicable |
Advisory Council Review |
Not Applicable |
Earliest Start Date |
June 2014 |
Expiration Date |
February 7, 2014 |
Due Dates for E.O. 12372 |
Not Applicable |
Required Application Instructions
It is critical that applicants follow the instructions in the Application Guide (SF424 (R&R) Application Guide or PHS 398 Application Guide, as appropriate) except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
Part 1. Overview Information
Part 2. Full Text of the Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission
Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
The mission of the NIH is to seek fundamental knowledge about the nature and behavior of living systems, and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The Office of Research on Women’s Health (ORWH) works in partnership with the NIH institutes, centers, and offices to ensure that research on women’s health and on sex and gender factors in health and illness is an integral part of the scientific framework.
This FY 2014 Administrative Supplement program is designed to support research that increases understanding of sex and gender differences and factors in health and disease, as part of the implementation of Goals 1 through 3 of the NIH Strategic Plan for Women's Health Research.
Women and men are characterized by both sex and gender, as highlighted in the Institute of Medicine (IOM) report, entitled Exploring the Biological Contributions to Human Health: Does Sex Matter? (2001). In this context, sex referred to being male or female according to reproductive organs and biologic functions assigned by chromosomal complement. Factors that contribute to biological sex differences include chromosomes, reproduction, and hormones. Gender referred to socially defined and derived expectations and roles rooted in biology and shaped by the environment and experience. Sex and gender are important considerations in many areas of research, including basic biological, psychological, social, and behavioral studies. Consideration of these variables is critical to the accurate interpretation and validation of research findings that affect the various aspects of women’s health and sex/gender differences research and to the development of personalized approaches to medicine. Sex and gender variables may also determine how health and disease processes differ among women, or between women and men, and inform the development and testing of preventive and therapeutic interventions in both sexes.
The 2010 NIH Strategic Plan for Women’s Health, Moving into the Future with New Dimensions and Strategies, includes six goals to advance women’s health and a number of specific objectives under each of the goals to which the reader is referred for examples of general areas in which sex/gender differences research is encouraged. This administrative supplement announcement requests applications which address the first three goals of the strategic plan. They are as follows:
These goals and their specific objectives encompass a broad range of research in basic and behavioral science, incorporation of sex/gender differences in the design of new communication approaches and technologies, and in medical technologies, medical devices and therapeutic drugs; and the development of approaches to personalized medicine. The research proposed in the supplement needs to clearly demonstrate how the funding will address at least one specific objective from among Goals 1 through 3. For a complete list of specific objectives under goals 1 through 3, please go to the NIH Strategic Plan for Women's Health Research.
Appropriate topics/studies include, but are not limited to, those listed below:
For purposes of the administrative supplement (and within the scope of the parent application) applicants may use the following types of approaches to address the mandate to perform analyses of outcome measures based on sex/gender:
Applicants requesting funds for sex/gender analysis of Phase III clinical trials or studies of conditions affecting only one sex will not be considered under this administrative supplement.
The funding mechanism being used to support this program, administrative supplements, can be used to cover cost increases that are associated with achieving certain new research objectives as long as they are within the original scope of the project. Any cost increases need to result from making modifications to the project in order to take advantage of opportunities that would increase the value of the project consistent with its originally approved objectives and purposes.
The research proposed under the administrative supplement program must be within the original scope of the parent grant. Applicants should propose research that, if successful, would contribute to a greater understanding of the implications of sex/gender factors affecting human health or disease outcomes.
The following types of applications are considered to fall within the scope of the parent grant. Applications that propose to add animal subjects or tissues in order to conduct exploratory sex-based analyses; applications that propose to increase statistical power of sex/gender differences analyses of human or animal subjects by adding more male or female subjects; applications that propose new sex/gender analyses of existing data sets that are adequately powered; and single sex applications that address how the data obtained will inform sex-based differences in health and disease that include plans for sex based comparisons. The supplement is not appropriate for Phase III clinical trials.
Applicants are strongly encouraged to discuss their proposed supplement project with the IC Program Official of the parent grant prior to submission of a supplement application in order to ensure that the supplement content area fits with the scientific priorities of the IC and is within the scope of the parent grant; and to ensure that the parent grant mechanism is one the IC will support for a supplement. In addition to contact with the IC Program Official for the parent grant, applicants are strongly encouraged to include the Scientific/Research Contact listed in Section VII. Agency Contacts in these communications..
Funding Instrument |
The funding instrument will be the same as the parent award. |
Application Types Allowed |
Non-competing Administrative Supplements |
Funds Available and Anticipated Number of Awards |
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. ORWH intends to commit up to $5.0M in FY 2014 to fund approximately 50 awards. |
Award Budget |
Budget requests may be for no more than $100,000 in total costs. Application budgets are limited to no more than the amount of the current parent award, and must reflect the actual needs of the proposed project. The funding mechanism being used to support this program, administrative supplements, can be used to cover cost increases that are associated with achieving certain new research objectives, as long as the research objectives are within the original scope of the project, or the cost increases are for unanticipated expenses within the original scope of the project. Any cost increases need to result from making modifications to the project that would increase or preserve the overall impact of the project consistent with its originally approved objectives and purposes. |
Award Project Period |
The project and budget periods must be within the currently approved project period for the existing parent award. All awards are for a one-year period. |
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.
All organizations administering an eligible parent award may apply for a supplement under this announcement.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Governments
Other
This announcement is for supplements to existing projects. To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment. The proposed supplement must be to provide for an increase in costs due to unforeseen circumstances. All additional costs must be within the scope of the peer reviewed and approved project.
IMPORTANT: The research proposed by the NIH grantee in the supplement
application must be within the original scope of the NIH-supported grant
project.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible
to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to
apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Applicant Organizations
Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.
Program Directors/Principal Investigators (PD(s)/PI(s))
All PD(s)/PI(s) must have an eRA Commons account and should work with their organizational officials to either create a new account or to affiliate an existing account with the applicant organization’s eRA Commons account. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.
Individual(s) must hold an active grant or cooperative
agreement, and the research proposed in the supplement must be accomplished
within the competitive segment of the active award. Individuals are invited to
work with their organizations to develop applications for support.
For supplements to parent awards that include multiple PDs/PIs, the supplement
may be requested by any or all of the PDs/PIs (in accordance with the existing
leadership plan) and submitted by the awardee institution of the parent award. Do
not use this administrative supplement application to add, delete, or change
the PDs/PIs listed on the parent award. Visit the Multiple Program
Director/Principal Investigator Policy in the SF424 (R&R) Application Guide
for more information.
PDs/PIs from applicant organizations who have received funding from the NIH Office of Research on Women's Health (ORWH) under PA-13-018 to supplement a specific grant, e.g., 1-RXX-IC-123456-02, are NOT eligible for supplement support under the current funding opportunity announcement for the same grant.
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
Only one application per parent award may be submitted.
Applicant organizations may submit more than one application, provided that each is sufficiently distinct from any other administrative supplement currently under consideration by the awarding NIH Institute or Center. Since applications in response to this announcement will only receive administrative review by the awarding Institute or Center, and will not receive a peer review, the NIH policy on resubmissions will not apply.
Only active awards with at least 18 months remaining at the time of submission will be considered. Awards in no-cost extension periods are not allowed to submit an application in response to this FOA.
Applicants are required to prepare applications according to
the current application forms in accordance with the Application Guide.
For electronic submissions, applicants must download the SF424 (R&R)
application package associated with this funding opportunity using the Apply
for Grant Electronically button in this announcement, or use the eRA Commons
streamlined submission process.
All forms should be completed for the supplemental
activities only and should not reflect funding or activities for the previously
awarded parent award.
It is critical that applicants follow the instructions in the Application Guide
(SF424
(R&R) Application Guide or PHS 398
Application Guide, as appropriate) except where instructed in this funding
opportunity announcement to do otherwise. Conformance to the requirements in
the Application Guide is required and strictly enforced. Applications that are
out of compliance with these instructions may be delayed or not accepted for
review.
For information on Application Submission and Receipt, visit Frequently Asked Questions Application Guide, Electronic Submission of Grant Applications.
All page limitations described in the Application Guide and the Table of Page Limits must be followed with the following modification:
The Research Strategy section of the administrative supplement may not exceed 6 pages.
Electronic submission of request for administrative supplements is only available for single-project activity codes for which competing applications are submitted electronically. Visit the list of single-project Activity Codes Processed Electronically by eRA to determine if the single-project activity code of the parent award has transitioned to electronic submission. Submission of requests for administrative supplements is for all other activity codes must use paper.
If the administrative supplement may be submitted electronically, then you may either (A) submit using the SF424 (R&R) Application Forms and Grants.gov/Apply, (B) submit using the streamlined submission process of eRA Commons, or (C) submit using the paper-based PHS 398 Application forms and the PHS 398 Application Guide.
Instructions for Submissions using Grants.gov/Apply for electronic-based submissions
For single project grants with activity codes that have transitioned to electronic submission using the SF424 (R&R) application forms, administrative supplement requests may be submitted electronically as a Revision application type on the R&R Cover Component. Prepare applications using the SF424 (R&R) application forms associated with this announcement. Please note that some components marked optional in the application package are required for submission of applications for this announcement. Follow all instructions in the SF424 (R&R) Application Guide to ensure you complete all appropriate required and optional components.
Special Instructions for Streamlined Submissions using the eRA Commons for electronic-based submissions
NIH now offers a streamlined system through the eRA Commons for submitting administrative supplements. Login to the eRA Commons, identify the parent award, and prepare an administrative supplement request. A User s Guide for submitting through this system is available.
Include the Research Strategy and any other required documentation (described below) as a PDF file using the Add Other Attachments function. Budget information should be entered for the grantee institution in the fields provided. There is no template or form available for subaward information; instead, all subaward information should be included as a separate attachment showing the funds requested (by budget period) using the same categories provided for the grantee institution. Also include a budget justification for the subawardee institution in the same file.
Instructions for Submissions using the PHS 398 Application Forms (for paper-based submissions)
Applications must be prepared using the PHS 398 research grant application forms and instructions for preparing a research grant application. The grantee institution, on behalf of the PD/PI of the parent award, must submit the request for supplemental funds directly to the awarding component that supports the parent award. Submit a signed, typewritten original of the application, including the checklist, and two signed photocopies in one package to:
ORWH Research Programs
Office of Research on Women's Health
Division of Program Coordination, Planning and
Strategic Initiatives
National Institutes of Health
6707 Democracy Blvd, Suite 400
Bethesda MD 20892-5484 (use ZIP: 20717 for expedited
delivery services)
Telephone: 301-435-1573
Email: [email protected]
On the face page of the application form, note that your application is in response to a specific program announcement, and enter the title and number of this announcement.
All instructions in the Application Guide must be followed for all Research Plan sections applicable to the proposed supplement activities. At a minimum, the Research Strategy section should be completed and must include a summary or abstract of the funded parent award or project. Other sections should also be included if they are being changed by the proposed supplement activities.
Research Strategy: As the first sentence of the Research Strategy section, applicants should include a statement of relevance of the proposed research to a minimum of one specific objective chosen from Goals 1 through 3 from the NIH Strategic Plan for Women's Health Research.
All instructions in the Application Guide must be followed, with the following additional instructions:
All instructions in the Application Guide must be followed, with the following additional instructions:
All budgets should be submitted using the R&R Detailed Budget form, regardless of the form used for the parent award, and should only include funds requested for the additional one year supplement activities.
A proposed budget should be submitted using the PHS 398 budget forms, in accordance with the PHS 398 Application Guide, and should only include funds requested for the additional supplement activities. All budgets must be limited to one year.
All instructions in the Application Guide must be followed, with the following additional instructions:
IACUC Documentation and IRB Documentation (Uploaded via the Other Attachments Section for electronic submissions)
The filename provided for each Other Attachment will be the name used for the bookmark in the electronic application in eRA Commons.
When conducting clinical research, follow all instructions for completing Planned Enrollment Reports as described in the SF424 (R&R) Application Guide.
Part I. Overview Information contains information about Key Dates. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission.
Organizations must submit applications as described above. Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration.
Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.
For electronic application submission, information on the
submission process and a definition of on-time submission are provided in the SF424(R&R)
Application Guide.
For paper-based application submission, information
on the process of receipt and determining if your application is considered
on-time is described in detail in the PHS 398 Application Guide.
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Pre-award costs are allowable only as described in the NIH Grants Policy Statement.
Applications must be submitted using the instructions specified above
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit Applying Electronically.
Important
reminders:
For applications submitted electronically on the SF424
(R&R) Application forms, all PD(s)/PI(s) must include their eRA Commons ID
in the Credential field of the Senior/Key Person Profile Component of
the SF 424(R&R) Application Package. Failure to register in the
Commons and to include a valid PD/PI Commons ID in the credential field will
prevent the successful submission of an electronic application to NIH.
The applicant organization must ensure that the DUNS number it provides on the
application is the same number used in the organization’s profile in the eRA
Commons and for the System for Award Management (SAM). Additional information
may be found in the Application Guide.
See more
tips for avoiding common errors.
Upon receipt, applications will be evaluated for completeness and/or responsiveness by the awarding Institute or Center. Applications that are incomplete and/or nonresponsive will not be reviewed.
Not Applicable
Administrative Supplements do not receive peer review. Instead, the administrative criteria described below will be considered in the administrative evaluation process.
The staff of the NIH awarding component will evaluate requests for a supplement to determine its overall merit. The following general criteria will be used:
Budget and Period of Support
NIH Staff will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Overall Impact
NIH staff will consider the ability of the proposed supplement activities to increase or preserve the parent award’s overall impact within the original scope of award:
Will the administrative supplement increase or preserve the likelihood for the program to exert a sustained, powerful influence on the research field(s) involved? Will the administrative supplement add significantly to IC sex/gender differences research?
In addition, each of the following criteria will be evaluated as applicable for the proposed supplement.
Protections for Human Subjects:
For research that involves human subjects but does
not involve one of the six categories of research that are exempt under 45 CFR
Part 46, NIH staff will evaluate the justification for involvement of human
subjects and the proposed protections from research risk relating to their
participation according to the following five review criteria: 1) risk to
subjects, 2) adequacy of protection against risks, 3) potential benefits to the
subjects and others, 4) importance of the knowledge to be gained, and 5) data
and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or
more of the six categories of research that are exempt under 45 CFR Part 46, NIH
staff will evaluate: 1) the justification for the exemption, 2) human subjects
involvement and characteristics, and 3) sources of materials. For additional
information on review of the Human Subjects section, please refer to the Guidelines
for the Review of Human Subjects.
Inclusion of Women, Minorities, and Children
When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of children to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.
Vertebrate Animals
NIH Staff will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: 1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; 2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; 3) adequacy of veterinary care; 4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and 5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Biohazards
NIH Staff will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
Administrative supplement requests will undergo an
administrative evaluation by NIH staff, but not a full peer review. Applications
submitted for this funding opportunity will be assigned to the awarding
component for the parent award and will be administratively evaluated using the
criteria shown above.
Not Applicable
A formal notification in the form of a Notice of Award (NoA)
will be provided to the applicant organization for successful applications.
This may be as an NoA for the supplemental activities only; alternatively, it
may be as either a revision to the current year NoA or included as part of a
future year NoA. The NoA signed by the grants management officer is the
authorizing document and will be sent via email to the grantee’s business
official.
Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection
of an application for award is not an authorization to begin performance. Any
costs incurred before receipt of the NoA are at the recipient's risk. These
costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to the DUNS, SAM
Registration, and Transparency Act requirements as noted on the Award
Conditions and Information for NIH Grants website.
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.
Cooperative Agreement Terms and Conditions of Award
Any supplements to Cooperative Agreements will be subject to the same Cooperative Agreement terms and conditions as the parent award.
Reporting requirements will be specified in the terms and conditions of award as applicable to the supplemental activities. In most non-competing continuation applications, the progress report and budget for the supplement must be included with, but clearly delineated from, the progress report and budget for the parent award. The progress report must include information about the activities supported by the supplement even if support for future years is not requested. Continuation of support for the supplement activities in the remaining years of the competitive segment of the grant will depend upon satisfactory review by the NIH awarding component of progress for both the parent award and the supplement project, the research proposed for the next budget period, and the appropriateness of the proposed budget for the proposed effort. This information is submitted with the Non-Competing Grant Progress Report, PHS 2590 or RPPR, and financial statements as required in the NIH Grants Policy Statement.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.
We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.
eRA Commons Help Desk (Questions regarding eRA Commons
registration, submitting and tracking an application, documenting system
problems that threaten submission by the due date, post submission issues)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)
Web ticketing system: https://public.era.nih.gov/commonshelp
TTY: 301-451-5939
Email: [email protected]
Grants.gov Customer Support (Questions
regarding Grants.gov registration and submission, downloading forms and
application packages)
Contact Center Telephone: 800-518-4726
Web ticketing system: https://grants-portal.psc.gov/ContactUs.aspx
Email: [email protected]
GrantsInfo (Questions regarding application instructions and
process, finding NIH grant resources)
Telephone 301-710-0267
TTY: 301-451-5936
Email: [email protected]
Mary C. Blehar, Ph.D.
Office of Research on Women’s Health (ORWH)
Telephone: 301-496-9006
Email: [email protected]
Mariela C. Shirley, Ph.D.
Office of Research on Women’s Health (ORWH)
Telephone: 301-496-7849
Email: [email protected]
Karen Parker, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-451-9462
Email: [email protected]
Lisa A. Neuhold, Ph.D.
National Eye Institute (NEI)
Telephone: 301-451-2020
Email: [email protected]
Shari Eason Ludlam, MPH
National Heart Lung and Blood Institute (NHLBI)
Telephone: 301-435-6667
Email: [email protected]
Jean E. McEwen, J.D., Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-496-7531
Email: [email protected]
Judy Hannah, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-435-0044
Email: [email protected]
Judith Arroyo, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-402-0717
Email: [email protected]
Tamara Lewis-Johnson, M.B.A., M.P.H.
National Institute of Allergy and Infectious Diseases
(NIAID)
Telephone: 301-451-7942
Email: [email protected]
Bernadette Tyree, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin
Diseases (NIAMS)
Telephone: 301-594-5055
Email: [email protected]
Rosemarie Hunziker, Ph.D.
National Institute of Biomedical Imaging and Bioengineering
(NIBIB)
Telephone: 301-451-1609
Email: [email protected]
Estella C Parrott, M.D., M.P.H.
Eunice Kennedy Shriver National Institute of Child Health
and Human Development (NICHD)
Telephone: 301-435-6971
Email: [email protected]
Susan Sullivan, Ph.D.
National Institute on Deafness and Other Communication
Disorders (NIDCD)
Telephone: 301-451-3841
Email: [email protected]
Jane Atkinson, D.D.S.
National Institute of Dental and Craniofacial Research
(NICDR)
Telephone: 301-435-7908
Email: [email protected]
Chris Mullins, Ph.D.
National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK)
Telephone: 301-451-5458
Email: [email protected]
Cora Lee Wetherington, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1319
Email: [email protected]
Caroline Dilworth, Ph.D.
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 919-541-7727
Email: [email protected]
Paula Flicker, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Telephone: 301-594-0828
Email: [email protected]
Kathleen O Leary, M.S.W.
National Institute of Mental Health (NIMH)
Telephone: 301-443-3945
Email: [email protected]
Jennifer Alvidrez, Ph.D.
National Institute on Minority Health and Health Disparities
(NIMHD)
Telephone: 301-594-9567
Email: [email protected]
Vicky Whittemore, PhD
National Institute of Neurological Disorders and Stroke
(NINDS)
Telephone: 301-496-1917
Email: [email protected]
Christine Jessup, Ph.D.
Fogarty International Center (FIC)
Telephone: 301-496-9676
Email: [email protected]
D. Lee Alekel, Ph.D.
National Center for Complementary and Alternative Medicine
(NCCAM)
Telephone: 301-443-8374
Email: [email protected]
Hua-Chuan Sim, M.D.
National Library of Medicine (NLM)
Telephone: 301-594-4882
Email: [email protected]
Amy Lossie, Ph.D.
Office of Behavioral and Social Sciences Research (OBSSR)
Telephone: 301-594-4574
Email: [email protected]
Not Applicable
Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 301-496-86340
Email: [email protected]
Mr. William W. Darby
National Eye Institute (NEI)
Telephone: 301-451-2020
Email: [email protected]
Kimberly O. Stanton
National Heart Lung and Blood Institute (NHLBI)
Telephone: 301-435-0159
Email: [email protected]
Cheryl Chick
National Human Genome Research Institute (NHGRI)
Telephone: 301-435-7858
Email: [email protected]
Richard E. Proper
National Institute on Aging (NIA)
Telephone: 301-402-7735
Email: [email protected]
Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704
Email: [email protected]
Lesia A. Norwood
National Institute of Allergy and Infectious Diseases
(NIAID)
Telephone: 301-402-7146
Email: [email protected]
Andrew Jones
National Institute of Arthritis and Musculoskeletal and Skin
Diseases (NIAMS)
Telephone: 301-435-0610
Email: [email protected]
Florence Turska
National Institute of Biomedical Imaging and Bioengineering
(NIBIB)
Telephone: 301-451-4782
Email: [email protected]
Bryan S. Clark, MBA
Eunice Kennedy Shriver National Institute of Child Health
and Human Development (NICHD)
Telephone: 301-435-6975
Email: [email protected]
Christopher Myers
National Institute on Deafness and Other Communication
Disorders (NIDCD)
Telephone: 301-402-0909
Email: [email protected]
Robert Munk
National Institute of Dental and Craniofacial Research
(NICDR)
Telephone: 301-594-4808
Email: [email protected]
Diana Ly
National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK)
Telephone: 301-594-9249
Email: [email protected]
Pamela Fleming
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6710
Email: [email protected]
Molly Puente, PhD
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 919-541-1373
Email: [email protected]
Lisa Moeller
National Institute of General Medical Sciences (NIGMS)
Telephone: 301-594-3914
Email: [email protected]
Tamara Kees
National Institute of Mental Health (NIMH)
Telephone: 301.443.8811
Email: [email protected]
Priscilla Grant, J.D., C.R.A.
National Institute on Minority Health and Health Disparities
(NIMHD)
Telephone: 301-594-8412
Email: [email protected]
Tijuanna Decoster
National Institute of Neurological Disorders and Stroke
(NINDS)
Telephone: 301-496 9231
Email: [email protected]
Bruce Butrum
Fogarty International Center (FIC)
Telephone: 301-496-1670
Email: [email protected]
George Tucker, MBA
National Center for Complementary and Alternative Medicine
(NCCAM)
Telephone: 301-594-8853
Email: [email protected]
Mable Nee
National Library of Medicine (NLM)
Telephone: 301-496-4221
Email: [email protected]
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
|
Department of Health and Human Services (HHS) |
|
|||
|
NIH... Turning Discovery Into Health® |
||||||